FAP and cancer: Using immunohistochemical analysis, Wikberg et al (90) found that FAPα was expressed by stromal fibroblasts in 85–90% of colorectal cancers and that increased FAPα expression in the cancer center, but not in the outlying regions, was associated with microsatellite instability, high CpG island methylator phenotype and poor prognosis.